Caprelsa Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Caprelsa: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15221.JPG
Vandetanib 100mg Tablet
AstraZeneca Pharmaceuticals LP
Pill Identification: Z 100 
Drug Image file DrugItem_15220.JPG
Caprelsa 100mg Tablet
AstraZeneca Pharmaceuticals LP
Pill Identification: Z 100 

What is this Medicine?

VANDETANIB (van DET a nib) is a medicine for certain types of thyroid cancer.

In-Depth Information

Caprelsa 100mg Tablet

NDC: 003107820
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Thyroid Cancer

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Caprelsa 100mg Tablet
Drug Image file DrugItem_15220.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: Z 100 
Shape: round
Color: white

Reported Side Effects for Caprelsa 100mg Tablet

Low Potassium Levels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Magnesium Levels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
<23.0%*
Severity: MILD
Onset: DELAYED
Inflamed Vocal Cords Incidence:
<23.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
<23.0%*
Severity: MILD
Onset: DELAYED
Keratopathy Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Corneal Opacification Incidence:
<13.0%*
Severity: SEVERE
Onset: DELAYED
Corneal Edema Incidence:
<13.0%*
Severity: MODERATE
Onset: EARLY
Corneal Deposits Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Throat Infection Incidence:
<23.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rhinitis Incidence:
<23.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Heart Failure Incidence:
0.9%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
High Calcium Levels Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
1.3%*
Severity: SEVERE
Onset: EARLY
Depression Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Low Calcium Levels Incidence:
2.0-6.0%*
Severity: SEVERE
Onset: DELAYED
High Magnesium Level Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
6.0%*
Severity: SEVERE
Onset: EARLY
Underactive Thyroid Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Hair Loss Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
8.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
9.0%*
Severity: SEVERE
Onset: EARLY
Onycholysis Incidence:
9.0%*
Severity: MILD
Onset: DELAYED
Blurred Vision Incidence:
9.0%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Protein In The Urine Incidence:
10.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Colon Incidence:
11.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
11.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
11.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
13.0-14.0%*
Severity: MODERATE
Onset: EARLY
Photosensitivity Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
13.0%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
15.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
15.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
21.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
21.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
23.0%*
Severity: MILD
Onset: DELAYED
Low Blood Sugar Incidence:
24.0%*
Severity: MODERATE
Onset: EARLY
High Blood Pressure Incidence:
33.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
33.0%*
Severity: MILD
Onset: EARLY
Drug-Induced Acne Incidence:
35.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
51.0%*
Severity: MODERATE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
53.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
53.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
53.0%*
Severity: MILD
Onset: EARLY
Long Qt Syndrome Incidence:
69.0%*
Severity: MODERATE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Caprelsa

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5